The poly lactide-co-glycolide acid (PLGA)-loaded aPD-1 NPs can impact CD40+ and CD11c populations in mice tumor models, impacting dendritic cells (DC) activation, intratumoral interferon-γ (IFN-γ) production, and the tumor burden decrement [6]. This evidence concerns the gene ITGAX and neoplasm.